Total Payments
$12,226
2024 Payments
$1,274
Companies
70
Transactions
536
Medicare Patients
2,207
Medicare Billing
$176,761
Payment Breakdown by Category
Food & Beverage$10,797 (88.3%)
Education$796.81 (6.5%)
Other$632.42 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,797 | 518 | 88.3% |
| Education | $796.81 | 11 | 6.5% |
| Long term medical supply or device loan | $632.42 | 7 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,178 | 47 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,077 | 38 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $918.35 | 35 | $0 (2024) |
| Daiichi Sankyo Inc. | $605.62 | 22 | $0 (2024) |
| Seagen Inc. | $603.81 | 29 | $0 (2023) |
| Amgen Inc. | $551.20 | 37 | $0 (2023) |
| GENZYME CORPORATION | $482.86 | 21 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $431.95 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $401.35 | 26 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $383.41 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,274 | 19 | E.R. Squibb & Sons, L.L.C. ($213.24) |
| 2023 | $2,813 | 120 | Janssen Biotech, Inc. ($355.57) |
| 2022 | $4,369 | 203 | Novartis Pharmaceuticals Corporation ($575.56) |
| 2021 | $3,770 | 194 | Janssen Biotech, Inc. ($455.74) |
All Payment Transactions
536 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $2.01 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: Oncology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $1.91 | General |
| Category: Oncology | ||||||
| 10/17/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: NONE | ||||||
| 09/10/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $71.59 | General |
| Category: DESMOID TUMORS | ||||||
| 08/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | PFIZER INC. | INLYTA (Drug) | Food and Beverage | In-kind items and services | $58.69 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.54 | General |
| 06/03/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $85.10 | General |
| 05/23/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $65.70 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $123.89 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $104.66 | General |
| Category: Oncology | ||||||
| 04/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $104.66 | General |
| Category: Oncology | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $123.48 | General |
| 02/22/2024 | Lilly USA, LLC | JAYPIRCA (Drug) | Food and Beverage | Cash or cash equivalent | $92.22 | General |
| Category: Oncology | ||||||
| 02/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $50.07 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $138.00 | General |
| Category: Oncology | ||||||
| 08/31/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Rare Disease | ||||||
| 08/30/2023 | Merck Sharp & Dohme LLC | REBLOZYL (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: HEMATOLOGY | ||||||
| 08/29/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Oncology | ||||||
| 08/29/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 565 | 967 | $126,581 | $48,565 |
| 2022 | 6 | 577 | 976 | $117,403 | $43,750 |
| 2021 | 8 | 579 | 963 | $119,030 | $51,864 |
| 2020 | 7 | 486 | 854 | $84,651 | $32,581 |
Total Patients
2,207
Total Services
3,760
Medicare Billing
$176,761
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 577 | $83,088 | $31,751 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 71 | $15,194 | $6,432 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 190 | $18,620 | $6,163 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $4,573 | $1,963 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,168 | $1,210 | 38.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 62 | 70 | $560.00 | $548.80 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 26 | $1,378 | $496.13 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 453 | $65,232 | $26,556 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 200 | 297 | $29,214 | $10,933 | 37.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 53 | $12,032 | $2,443 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $6,534 | $2,259 | 34.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 61 | 72 | $3,847 | $1,357 | 35.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 68 | $544.00 | $201.78 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 184 | 402 | $57,801 | $25,896 | 44.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 187 | 270 | $26,564 | $11,385 | 42.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 84 | 145 | $15,950 | $6,772 | 42.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 38 | $6,080 | $2,550 | 41.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $6,329 | $2,485 | 39.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 18 | $3,693 | $1,727 | 46.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 39 | 45 | $2,509 | $1,019 | 40.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 12 | 13 | $104.00 | $31.80 | 30.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 105 | 246 | $28,670 | $11,645 | 40.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 154 | 273 | $26,208 | $7,947 | 30.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 76 | 142 | $15,140 | $6,774 | 44.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 40 | $6,080 | $2,741 | 45.1% |
About Amy Baker, APRN
Amy Baker, APRN is a Nurse Practitioner healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1932532934.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Baker, APRN has received a total of $12,226 in payments from pharmaceutical and medical device companies, with $1,274 received in 2024. These payments were reported across 536 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($10,797).
As a Medicare-enrolled provider, Baker has provided services to 2,207 Medicare beneficiaries, totaling 3,760 services with total Medicare billing of $176,761. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Adult Health
- Location Paducah, KY
- Active Since 08/13/2013
- Last Updated 07/30/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1932532934
Products in Payments
- KISQALI (Drug) $641.63
- DARZALEX (Biological) $496.12
- IMBRUVICA (Drug) $470.89
- OPDIVO (Biological) $431.95
- LIBTAYO (Biological) $394.46
- Tavalisse (Drug) $360.05
- KEYTRUDA (Biological) $344.60
- Enhertu (Drug) $273.44
- TAGRISSO (Drug) $239.08
- SOMATULINE DEPOT (Drug) $235.33
- ENHERTU (Drug) $208.91
- MONJUVI (Drug) $191.42
- BESREMI (Drug) $178.05
- Lenvima (Drug) $176.21
- ENHERTU (Biological) $164.74
- NERLYNX (Drug) $164.45
- SARCLISA (Biological) $160.34
- ERLEADA (Drug) $158.03
- BRUKINSA (Drug) $153.41
- TUKYSA (Drug) $150.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Paducah
Aaron Garrett, Aprn, Np-C, APRN, NP-C
Nurse Practitioner — Payments: $7,678
Nurse Practitioner $7,678
Kaci Medley, Aprn, APRN
Nurse Practitioner — Payments: $6,863
Nurse Practitioner $6,863
Mrs. Laura Kelso, Fnp-Bc, FNP-BC
Nurse Practitioner — Payments: $5,539
Nurse Practitioner $5,539
Jacquelyn Van Waters, Np-C, NP-C
Nurse Practitioner — Payments: $4,908
Nurse Practitioner $4,908
Cheryl Vinson, Aprn, APRN
Nurse Practitioner — Payments: $4,452
Nurse Practitioner $4,452
Jennifer Thomas, Arnp, ARNP
Nurse Practitioner — Payments: $4,339
Nurse Practitioner $4,339